48 results on '"Rancati, Tiziana"'
Search Results
2. Skin dose-volume predictors of moderate-severe late side effects after whole breast radiotherapy
3. Worsening of 2-year patient-reported intestinal functionality after radiotherapy for prostate cancer including pelvic node irradiation
4. Voxel-based analysis: Roadmap for clinical translation
5. Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer
6. Validation of prediction models for radiation-induced late rectal bleeding: Evidence from a large pooled population of prostate cancer patients
7. Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer
8. REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer
9. 2937: Dose deposition in sub-regions of breast relates to acute and persistent pain after radiotherapy
10. 2516: NTCP model of acute toxicity after whole breast irradiation: training and extended validation
11. 2449: A loco-systemic score characterizing microvascular health predicts skin reactions after breast RT
12. 2437: Clinical predictors of late lymphopenia in PCa patients undergoing radical or post-operative WPRT
13. 2403: Specific dose optimization driven by late toxicity subregions in prostate cancer treatment plans
14. 2391: Longitudinal assessment of the impact of pelvic nodal radiotherapy on lymphopenia in PCa treatment
15. 2302: Development of Pancreatic Ductal AdenoCarcinoma on-chip for radiobiological applications
16. 2287: Bone marrow dose-volume predictors of late lymphopenia after pelvic lymph node irradiation for PCa
17. 2276: Skin Dose-volume Predictors of Late Fibrosis-related Toxicity after Whole Breast Radiotherapy
18. 2088: Fat necrosis after One-week Partial Breast Irradidation VS Standard of Care: a case-control study.
19. 1984: Cox-based prediction model of grade 5 bleeding after SBRT of ultra-centrally located lung tumors
20. 1963: Identifying spatial dose patterns predictive of haematological toxicity after prostate cancer RT
21. 1944: KB plan prediction model for whole breast irradiation: an international inter-consortium experience
22. 1568: Toward multi-institutional Knowledge-Based benchmark for right and left whole breast irradiation
23. 1378: Genetically-based analysis of dose surface maps for assessing toxicity post-RT: an innovative method
24. 1242: Sensitivity of dose-response mapping model parameters at the bladder and rectum in prostate cancer
25. 1240: Fusobacterium associates with a better prognosis and radiosensitizes head and neck cancers
26. 848: Treatment laterality and incidental dose to internal mammary nodes and axilla in breast radiotherapy
27. Patient-reported urinary incontinence after radiotherapy for prostate cancer: Quantifying the dose–effect
28. Patient-reported intestinal toxicity from whole pelvis intensity-modulated radiotherapy: First quantification of bowel dose–volume effects
29. First application of a pixel-wise analysis on bladder dose–surface maps in prostate cancer radiotherapy
30. Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study
31. The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study
32. Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation
33. Relationships between bladder dose–volume/surface histograms and acute urinary toxicity after radiotherapy for prostate cancer
34. Long term rectal function after high-dose prostatecancer radiotherapy: Results from a prospective cohort study
35. 3362: Incorporating genetic information in dose-response relationships
36. Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer
37. Clinical and dosimetric predictors of late rectal toxicity after conformal radiation for localized prostate cancer: Results of a large multicenter observational study
38. Dose–volume effects for normal tissues in external radiotherapy: Pelvis
39. Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: Bowel dose-volume effect quantification in a multicentric cohort study
40. Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different models
41. Local dose analysis to predict acute and late urinary toxicities after prostate cancer radiotherapy: Assessment of cohort and method effects
42. REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer
43. Multi-variable models of large International Prostate Symptom Score worsening at the end of therapy in prostate cancer radiotherapy
44. Multi-variable models predicting specific patient-reported acute urinary symptoms after radiotherapy for prostate cancer: Results of a cohort study
45. Correlation between surrogates of bladder dosimetry and dose–volume histograms of the bladder wall defined on MRI in prostate cancer radiotherapy
46. Increasing the risk of late rectal bleeding after high-dose radiotherapy for prostate cancer: The case of previous abdominal surgery. Results from a prospective trial
47. Long-term biochemical control of prostate cancer after standard or hyper-fractionation: Evidence for different outcomes between low–intermediate and high risk patients
48. Inclusion of clinical risk factors into NTCP modelling of late rectal toxicity after high dose radiotherapy for prostate cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.